BioInvent International AB

BioInvent International AB

BioInvent International AB

Overview
Date Founded

1996

Headquarters

Sölvegatan 41,Lund, Skane 223 70

Type of Company

Public

Employees (Worldwide)

56

Industries

Pharmaceuticals
Biotechnology

Company Description

BioInvent International AB engages in the research and development of immunomodulating antibodies for the treatment of cancer. The firm's clinical platform include n-CoDeR antibody library and the unique F.I.R.S.T. development tool. It operates through apParent segment. The company was founded in 1996 and is headquartered in Lund, Sweden.

Contact Data
Trying to get in touch with decision makers at BioInvent International AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Scientific Officer

Director

Senior Vice President, Technical Operations

Senior Vice President, Corporate Development

Chief Financial Officer

Chief Medical Officer

Senior Director Investor Relations

Director & Biomedical Scientist

Board of Directors

Former Consultant at McKinsey & Co., Inc.

Chief Medical Officer & Head-Development at AlzeCure Pharma AB

Director at BioInvent International AB

Chief Executive Officer at Quorics BV

Co-Founder at CryptoMedix, Inc.

Executive Chairman at Delenex Therapeutics AG

BioInvent International AB

Paths to BioInvent International AB
Potential Connections via
Relationship Science
You
BioInvent International AB
Advisors & Consultants
Legal Advisor

Chair, Life Sciences Practice at Wiggin & Dana LLP

Auditor

Authorized Public Accountant at KPMG LLP

Clients

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Key Stats and Financials As of 2019
Market Capitalization
$230M
Total Enterprise Value
$46.9M
Earnings Per Share
$-0.85
EBITDAMargin
-140.43%
Three Year Compounded Annual Growth Rate Of Revenue
9.56%
Five Year Compounded Annual Growth Rate Of Revenue
14.84%
Enterprise Value / Sales
4.44x
Debt TEV
0.04x
TEVNet Income
-3x
Revenue
$10.6M
EBITDA
$-14.8M
Total Equity
$19.1M
Net Profit
$-15.6M
Total Debt
$1.75M
Suppliers
Cancer Research UK Hospitals & Patient Services | London, United Kingdom

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by BioInvent International AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of BioInvent International AB's profile does not indicate a business or promotional relationship of any kind between RelSci and BioInvent International AB.